The cost effectiveness of biologic therapy for the treatment of chronic plaque psoriasis in real practice settings in Italy.

MLA

Spandonaro, Federico, et al. “The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in Italy.” BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, vol. 28, no. 3, June 2014, pp. 285–95. EBSCOhost, https://doi.org/10.1007/s40259-014-0084-3.

APA

Spandonaro, F., Ayala, F., Berardesca, E., Chimenti, S., Girolomoni, G., Martini, P., Peserico, A., Polistena, B., Puglisi Guerra, A., Vena, G. A., Altomare, G., & Calzavara Pinton, P. (2014). The cost effectiveness of biologic therapy for the treatment of chronic plaque psoriasis in real practice settings in Italy. BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, 28(3), 285–295. https://doi.org/10.1007/s40259-014-0084-3

Chicago

Spandonaro, Federico, Fabio Ayala, Enzo Berardesca, Sergio Chimenti, Giampiero Girolomoni, Patrizia Martini, Andrea Peserico, et al. 2014. “The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in Italy.” BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 28 (3): 285–95. doi:10.1007/s40259-014-0084-3.